Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
50,729,161
-
Share change
-
-93,216
-
Total reported value
-
$3,578,385,438
-
Put/Call ratio
-
126%
-
Price per share
-
$70.59
-
Number of holders
-
243
-
Value change
-
-$462,168
-
Number of buys
-
109
-
Number of sells
-
133
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2021
As of 30 Sep 2021 HAEMONETICS CORP - Common Stock (HAE) had 243 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 50,729,161 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Neuberger Berman Group LLC, STATE STREET CORP, FRANKLIN RESOURCES INC, WESTFIELD CAPITAL MANAGEMENT CO LP, JANUS HENDERSON GROUP PLC, LGT CAPITAL PARTNERS LTD., and Capital Research Global Investors.
This table shows 243 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.